` ITCI (Intra-Cellular Therapies Inc) vs DPH (Dechra Pharmaceuticals PLC) Comparison - Alpha Spread

ITCI
vs
DPH

Over the past 12 months, ITCI has significantly outperformed DPH, delivering a return of 94% compared to the DPH's 0% growth.

Valuation Comparison

ITCI Intrinsic Value
91.9 USD
Overvaluation 30%
Intrinsic Value
Price
DPH Intrinsic Value
Not Available
Company Last Price Intrinsic Value DCF Value Relative Value Wall St Target
Intra-Cellular Therapies Inc
NASDAQ:ITCI
131.87 USD
91.9 USD
Overvalued by 30%
132.57 USD
1% Undervalued
51.22 USD
61% Overvalued
Not Available
Dechra Pharmaceuticals PLC
LSE:DPH
3 866 GBX
Not Available Not Available Not Available Not Available

Financials Comparison

Growth Over Time
ITCI vs DPH

ITCI
DPH
Add Stock
Revenue
www.alphaspread.com
Company LTM Historical Growth Growth Streak % Positive Years Max Drawdown Volatility Forecasted Growth
3 Years 5 Years 10 Years 1 Year 3 Years
Intra-Cellular Therapies Inc
Revenue
Dechra Pharmaceuticals PLC
Revenue

All metrics are calculated based on data from the last 10 years.

Profitability Comparison

Free Cash Flow
ITCI vs DPH

ITCI
DPH
Add Stock
Free Cash Flow
www.alphaspread.com
Company LTM Average Historical Growth FCF Margin Conversion
3 Years 5 Years 3 Years 5 Years 10 Years
Intra-Cellular Therapies Inc
NASDAQ:ITCI
Dechra Pharmaceuticals PLC
LSE:DPH
What is Free Cash Flow?

Gross Margin

ITCI
91.6%
DPH
56.4%

Operating Margin

ITCI
-17.1%
DPH
3.3%

Net Margin

ITCI
-11%
DPH
-3.7%

FCF Margin

ITCI
-10.8%
DPH
4.4%

ROE

ITCI
-8.6%
DPH
-3.9%

ROA

ITCI
-7.1%
DPH
-2%

ROIC

ITCI
-42.1%
DPH
1.6%

ROCE

ITCI
-13.2%
DPH
2%

Stocks Performance

Stocks Performance
ITCI vs DPH

Loading

Performance Gap
ITCI vs DPH

Loading
ITCI
DPH
Difference
www.alphaspread.com

Performance By Year
ITCI vs DPH

Loading
ITCI
DPH
Add Stock
Unlock Full Access to Alpha Spread
Create Free Account